Table 2.
Downgraded lesions by the DTL model and histopathology results in the validation set
| R | N1 | N2 | Histologically benign |
Histologically malignant |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 A | 4B | 4 C | 4 A | 4B | 4 C | 4 A | 4B | 4 C | 4 A | 4B | 4 C | |||||
| R1 | 29 | 22 | 19 | 27 | 19 | 16 | DTL benign | 26 | 18 | 14 | 1 | 1 | 2 | |||
| DTL malignant | 1 | 1 | 0 | 1 | 2 | 3 | ||||||||||
| R2 | 32 | 20 | 22 | 29 | 16 | 17 | DTL benign | 28 | 15 | 15 | 1 | 1 | 2 | |||
| DTL malignant | 1 | 0 | 1 | 2 | 4 | 4 | ||||||||||
| R3 | 29 | 19 | 20 | 26 | 17 | 16 | DTL benign | 25 | 15 | 14 | 1 | 2 | 2 | |||
| DTL malignant | 1 | 0 | 1 | 2 | 2 | 3 | ||||||||||
| R4 | 31 | 24 | 21 | 27 | 21 | 17 | DTL benign | 26 | 19 | 14 | 1 | 2 | 3 | |||
| DTL malignant | 1 | 0 | 0 | 3 | 3 | 4 | ||||||||||
| R5 | 30 | 20 | 24 | 28 | 16 | 19 | DTL benign | 27 | 14 | 16 | 1 | 2 | 3 | |||
| DTL malignant | 0 | 0 | 1 | 2 | 4 | 4 | ||||||||||
| Total | 151 | 105 | 106 | 137 | 89 | 85 | 136 | 82 | 76 | 15 | 23 | 30 | ||||
Note: R, resident; N1, number of BI-RADS 4 lesions diagnosed by residents; N2, number of downgraded lesions according to the DTL model